Telix Pharmaceuticals's total assets for Q4 2025 were AU$1.77B, an increase of 48.97% from the previous quarter. TLPPF total liabilities were AU$1.15B for the fiscal quarter, a 49.71% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.